Edition:
United States

Cryoport Inc (CYRX.OQ)

CYRX.OQ on NASDAQ Stock Exchange Capital Market

8.55USD
10:09am EST
Change (% chg)

$-0.02 (-0.23%)
Prev Close
$8.57
Open
$8.60
Day's High
$8.60
Day's Low
$8.50
Volume
4,193
Avg. Vol
52,197
52-wk High
$10.40
52-wk Low
$1.96

Chart for

About

Cryoport, Inc. (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen... (more)

Overall

Beta: 0.97
Market Cap(Mil.): $218.89
Shares Outstanding(Mil.): 25.54
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 76.31 16.04
EPS (TTM): -- -- --
ROI: -- -0.90 35.70
ROE: -- -3.73 15.40

BRIEF-Cryoport revenue up 52 percent driven by BioPharma

* Revenue increased 52 percent to $3.0 million for three month period ended September 30, 2017​

Nov 02 2017

BRIEF-Cryoport to support commercial launch of Kite Pharma's CAR-T therapy, axi-cel​

* Cryoport Inc - ‍Cryoport selected to support potential commercial launch of Kite Pharma's CAR-T Therapy Axicabtagene Ciloleucel​

Sep 05 2017

BRIEF-Cryoport reports Q2 loss per share $0.08

* Cryoport revenue up 52% for the second quarter of 2017, driven by biopharma

Aug 08 2017

BRIEF-Cryoport says Novartis signed agreement contracting co over an initial three-year term for cryogenic logistics support

* Cryoport - Novartis signed agreement contracting co over an initial three-year term for cryogenic logistics support of CTL019/CD19 CAR-T cell therapy Source text for Eikon: Further company coverage:

Jul 25 2017

Earnings vs. Estimates